Previous studies demonstrated that lipopolysaccharide (LPS)-induced organ injury in rodents and that plasma HGF concentrations were increased in patients with systemic inflammatory response syndrome and early-phase sepsis [7, 8]; these increase of HGF are suggested to serve a compensatory mechanism to minimize LPS-induced cell and organ injury. This evidence concerns the gene HGF and systemic inflammatory response syndrome.